COSMOS Pharmaceutical Statistics

Total Valuation

COSMOS Pharmaceutical has a market cap or net worth of JPY 580.16 billion. The enterprise value is 555.56 billion.

Market Cap	580.16B
Enterprise Value	555.56B

Important Dates

The last earnings date was Friday, October 11, 2024.

Earnings Date	Oct 11, 2024
Ex-Dividend Date	Nov 28, 2024

Share Statistics

COSMOS Pharmaceutical has 79.26 million shares outstanding. The number of shares has increased by 0.05% in one year.

Shares Outstanding	79.26M
Shares Change (YoY)	+0.05%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	51.81%
Owned by Institutions (%)	24.82%
Float	33.32M

Valuation Ratios

The trailing PE ratio is 23.72 and the forward PE ratio is 21.51. COSMOS Pharmaceutical's PEG ratio is 3.07.

PE Ratio	23.72
Forward PE	21.51
PS Ratio	0.60
PB Ratio	2.51
P/FCF Ratio	n/a
PEG Ratio	3.07

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.80, with an EV/FCF ratio of -874.90.

EV / Earnings	22.72
EV / Sales	0.58
EV / EBITDA	10.80
EV / EBIT	17.64
EV / FCF	-874.90

Financial Position

The company has a current ratio of 0.72, with a Debt / Equity ratio of 0.15.

Current Ratio	0.72
Quick Ratio	0.30
Debt / Equity	0.15
Debt / EBITDA	0.66
Debt / FCF	-53.64
Interest Coverage	318.20

Financial Efficiency

Return on equity (ROE) is 11.05% and return on invested capital (ROIC) is 7.96%.

Return on Equity (ROE)	11.05%
Return on Assets (ROA)	4.39%
Return on Capital (ROIC)	7.96%
Revenue Per Employee	175.07M
Profits Per Employee	4.44M
Employee Count	5,512
Asset Turnover	2.15
Inventory Turnover	9.49

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.91% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-7.91%
50-Day Moving Average	7,132.28
200-Day Moving Average	7,069.15
Relative Strength Index (RSI)	51.85
Average Volume (20 Days)	358,345

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, COSMOS Pharmaceutical had revenue of JPY 964.99 billion and earned 24.45 billion in profits. Earnings per share was 308.61.

Revenue	964.99B
Gross Profit	188.31B
Operating Income	31.50B
Pretax Income	33.72B
Net Income	24.45B
EBITDA	51.43B
EBIT	31.50B
Earnings Per Share (EPS)	308.61

Full Income Statement

Balance Sheet

The company has 52.30 billion in cash and 34.06 billion in debt, giving a net cash position of 18.24 billion or 230.11 per share.

Cash & Cash Equivalents	52.30B
Total Debt	34.06B
Net Cash	18.24B
Net Cash Per Share	230.11
Equity (Book Value)	231.44B
Book Value Per Share	2,920.11
Working Capital	-58.90B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 55.18 billion and capital expenditures -55.81 billion, giving a free cash flow of -635.00 million.

Operating Cash Flow	55.18B
Capital Expenditures	-55.81B
Free Cash Flow	-635.00M
FCF Per Share	-8.01

Full Cash Flow Statement

Margins

Gross margin is 19.51%, with operating and profit margins of 3.26% and 2.53%.

Gross Margin	19.51%
Operating Margin	3.26%
Pretax Margin	3.49%
Profit Margin	2.53%
EBITDA Margin	5.33%
EBIT Margin	3.26%
FCF Margin	-0.07%

Dividends & Yields

This stock pays an annual dividend of 65.00, which amounts to a dividend yield of 0.89%.

Dividend Per Share	65.00
Dividend Yield	0.89%
Dividend Growth (YoY)	20.00%
Years of Dividend Growth	1
Payout Ratio	19.05%
Buyback Yield	-0.05%
Shareholder Yield	0.83%
Earnings Yield	4.22%
FCF Yield	-0.11%

Dividend Details

Stock Splits

The last stock split was on August 29, 2024. It was a forward split with a ratio of 2.

Last Split Date	Aug 29, 2024
Split Type	Forward
Split Ratio	2

Scores

COSMOS Pharmaceutical has an Altman Z-Score of 4.22.

Altman Z-Score	4.22
Piotroski F-Score	n/a